Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01657448Phase 3Completed
A Phase 3 trial of methenamine, methylene blue in dysuria, sponsored by EMS. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01657448.